G. Cohuet

发表

Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.

P. Jones, J. Wedzicha, J. Vestbo, 2014, Respiratory medicine.

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Dave Singh, J. Vestbo, M. Corradi, 2017, The Lancet.

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

N. Roche, Dave Singh, J. Vestbo, 2018, The Lancet.

The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study).

Dave Singh, Z. Siergiejko, M. Hoffmann, 2016, Respiratory medicine.

Corrigendum to “Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations” [Respir Med 108 (2014) 1153–1162]

J. Wedzicha, Dave Singh, J. Vestbo, 2015 .

P271 Effect of extrafine single inhaler triple therapy on lung function and use of rescue medication: results from the trinity study

M. Corradi, A. Papi, S. Vezzoli, 2017, Thorax.

P273 Association of incident pneumonia and exacerbations with extrafine triple therapy in one single inhaler in copd patients: a post-hoc analysis from trilogy and trinity studies

M. Corradi, A. Papi, S. Vezzoli, 2017, Thorax.

Mechanisms of target organ damage caused by hypertension: therapeutic potential.

G. Cohuet, G Cohuet, H Struijker-Boudier, 2006, Pharmacology & therapeutics.

Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone.

H. van Essen, M. D. de Gooyer, P. Hilbers, 2008, Endocrinology.

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, J. Vestbo, M. Corradi, 2016, The Lancet.

Mechanical properties and structure of carotid arteries in mice lacking desmin.

P. Challande, P. Boutouyrie, P. Boutouyrie, 2001, Cardiovascular research.

Mechanical Strength of the Isolated Carotid Artery in SHR

A. Dominiczak, P. Challande, S. Laurent, 2001, Hypertension.

The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis

M. Safar, H. S. Boudier, M. Baumann, 2003, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations

J. Wedzicha, Dave Singh, J. Vestbo, 2012, European Respiratory Journal.

Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations

J. Wedzicha, Dave Singh, J. Vestbo, 2015 .

Efficacy and Safety of CHF6001, A Novel Inhaled PDE4 Inhibitor in COPD: The Pioneer Dose Finding Study

S. Petruzzelli, G. Cohuet, M. Govoni, 2019, C32. COPD: TRANSLATIONAL AND MECHANISTIC STUDIES.

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, J. Vestbo, M. Corradi, 2016, The Lancet.